Latest Regulatory Trends Impacting the Nutraceutical Excipients Market

The global nutraceutical excipients market size is estimated to account for about USD 3.4 billion in 2020 and projected to reach a value of nearly USD 4.9 billion by 2025, growing at a CAGR of 7.3% from 2020 to 2025. The market for nutraceutical excipients market has been growing in accordance with the rise in demand and consumption for nutraceuticals, around the globe. The consumption of dietary supplements in the form of tablets and capsules has been witnessing an upsurge demand in recent times, owing to the growing awareness for health benefits offered by these products that helps to support the wellbeing of the consumers. The key driving factors of the nutraceutical excipients market include increasing consumer concerns regarding maintaining a balanced diet and growing consumer awareness about several diseases caused due to lack of intake of necessary nutrients as a result of imbalanced dietary lifestyles. Food fortification is one of the major trends, which is also fueling the nutraceutical excipients market in the functional food & beverage industry.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247060367

Driver: Advancements in nanotechnology equipped with new features to drive the growth of the market

Nanotechnology-enabled drug delivery systems (NDDS) are used to cater to the issue of drug toxicity. There are two major approaches to use nanotechnology as a drug delivery system (DDS). The first is to reduce the size of nutraceutical drug crystals to ensure enhanced solubility and bioavailability, while the second approach is to use some form of nano-carrier for effective delivery of active ingredients. In March 2009, the scientific committee of the European Food Safety Agency published an opinion on nanoscience and nanotechnology regarding food and feed safety. A document offering guidance on how to assess potential risks associated with certain food-related uses of nanotechnology was followed in May 2011, providing practical recommendations to regulators on how to assess applications that use engineered nanomaterials in food additives, enzymes, flavorings, food contact materials, novel foods, food supplements, feed additives, and pesticides.

Poor drug physicochemical properties can be improved by associating the drug with a pharmaceutical carrier. A drug delivery system (DDS) can enhance a drug’s pharmacokinetics and cellular penetration. Moreover, the drug delivery system (DDS) may also address obstacles arising from low drug solubility, degradation, fast clearance rates, nonspecific toxicity, and inability to cross biological barriers. Hence, the use of nanotechnology for improving the functionalities of excipients is also projected to drive the growth of the nutraceutical excipients market during the forecast period.

Restraint: Decrease in returns on R&D investments and high costs of clinical trials and registration.

Excipients and nutraceutical products are clinically and chemically developed, and hence, require extensive R&D investments, clinical trials, and approvals from respective authorities in different countries/regions. In addition, developing such products is not a short-term activity, as it includes the formulation, trial & testing, and commercializing it into the market. However, high R&D investments do not give equal returns in terms of productivity, as even after successful molecule discovery, the cost of bringing a new nutraceutical product and a new excipient into the market is significantly high. In addition, other players in the market develop alternate and cheaper solutions, amidst the trial and testing procedures of one product or solution by another company, which leads to wastage of time, money, and efforts required to come to the later stages of that product, thereby disrupting the complete process of new product development. At the same time, the risk of failure also remains high. The cost of proving the effectiveness of an excipient through clinical trials is also relatively expensive and can be a major hindrance to the development of novel excipients in the market.

The segment estimated to account for the largest share in the nutraceutical excipients market in 2020, by end-product is the probiotics segments.

Probiotics are yeast and good bacteria that are beneficial for consumers, as they enhance digestion and gut health, improve immunity, increase nutrient absorption, and lower the chances of food allergies. Probiotic products are offered in different forms, including yogurt and drinks, and supplement forms such as tablets and capsules. However, there are two main challenges to develop a probiotic formulation viable for commercial utilization. The first one is the quality of health attributes that the probiotic organisms can confer, and the second one is the stability of the formulation till the end of its shelf life. Companies are focusing on developing and offering probiotic blend products, which includes APIs (Active Pharmaceutical Ingredient), containing probiotic formulations by using different types of excipients. Among the excipients used in these blends for probiotics formulation, mannitol was found the most suitable, which helped in the enhancement of the shelf life of end-products.

Make an Inquiry:
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=247060367

North America dominated the global nutraceutical excipients market in 2019; however, Asia Pacific market is projected to grow at the highest CAGR during the forecast period.

North America accounted for the largest market share in 2019. The market in North America is dominating, owing to the concentration of the global players such as DuPont (US), Kerry (Ireland), Cargill (US), and Ingredion (US). The market for nutraceutical excipients here is mature, and hence, the growth is moderate compared to other regions. Other factors contributing to the growth of nutraceutical excipients in North American region include the busy lifestyle of consumers, prevalence of chronic diseases due to hectic lifestyles, and an increase in awareness among consumers regarding the health benefits of nutritional foods, including food supplements, which has driven the demand for functional food products. In addition, the use of technological advancements and new product launches have made excipients available for a wide range of applications in the fortified food & beverage, dietary supplements, and nutraceuticals sectors, which is projected to drive the growth of the market in the region.

Key Market Players:

This report includes a study of marketing and development strategies, along with the product portfolios of the leading companies in the market. The key players in the market include The nutraceutical excipients market also consists of key start-up players, which include IMCD (Netherlands), Hilmar Ingredients (US), Innophos Holdings Inc (US), JRS Pharma (Germany), Biogrund GmbH (Germany), Pharma Line Int'l Corp (South Korea), Jigs Chemical (India), Panchamrut Chemicals (India), Azelis Chemical Ltd (Europe), and Daicel Group (Japan).